|   News

Spring 2018 IPO News


Two Atlas portfolio companies that are transforming the way cancer is treated, Surface Oncology and Unum Therapeutics, completed successful IPOs in the spring of 2018. Both had concurrent private placements from key pharmaceutical partners, and both will be advancing clinical stage programs with the new financings.

Read the highlights.